Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2017/7869412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565121967194112 |
|---|---|
| author | Sang Jin Lee Won Park Sung Hwan Park Seung-Cheol Shim Han Joo Baek Dae-Hyun Yoo Hyun Ah Kim Soo Kon Lee Yun Jong Lee Young Eun Park Hoon-Suk Cha Jin Kyun Park Eun Young Lee Eun Bong Lee Yeong Wook Song |
| author_facet | Sang Jin Lee Won Park Sung Hwan Park Seung-Cheol Shim Han Joo Baek Dae-Hyun Yoo Hyun Ah Kim Soo Kon Lee Yun Jong Lee Young Eun Park Hoon-Suk Cha Jin Kyun Park Eun Young Lee Eun Bong Lee Yeong Wook Song |
| author_sort | Sang Jin Lee |
| collection | DOAJ |
| format | Article |
| id | doaj-art-afbe4a820e3b4439ad7103ca8b4b2ddc |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-afbe4a820e3b4439ad7103ca8b4b2ddc2025-02-03T01:09:12ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/78694127869412Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”Sang Jin Lee0Won Park1Sung Hwan Park2Seung-Cheol Shim3Han Joo Baek4Dae-Hyun Yoo5Hyun Ah Kim6Soo Kon Lee7Yun Jong Lee8Young Eun Park9Hoon-Suk Cha10Jin Kyun Park11Eun Young Lee12Eun Bong Lee13Yeong Wook Song14Division of Rheumatology, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Inha University Hospital, Incheon, Republic of KoreaDivision of Rheumatology, The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Eulji University Hospital, Daejeon, Republic of KoreaDivision of Rheumatology, Gachon University Gil Medical Center, Incheon, Republic of KoreaDivision of Rheumatology, Hanyang University Medical Center, Seoul, Republic of KoreaDivision of Rheumatology, Hallym University Medical Center, Anyang, Republic of KoreaDivision of Rheumatology, Yonsei University Health System, Seoul, Republic of KoreaDivision of Rheumatology, Seoul National University Bundang Hospital, Seongnam, Republic of KoreaDivision of Rheumatology, Pusan National University Hospital, Busan, Republic of KoreaDivision of Rheumatology, Samsung Medical Center, Seoul, Republic of KoreaDivision of Rheumatology, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Seoul National University Hospital, Seoul, Republic of Koreahttp://dx.doi.org/10.1155/2017/7869412 |
| spellingShingle | Sang Jin Lee Won Park Sung Hwan Park Seung-Cheol Shim Han Joo Baek Dae-Hyun Yoo Hyun Ah Kim Soo Kon Lee Yun Jong Lee Young Eun Park Hoon-Suk Cha Jin Kyun Park Eun Young Lee Eun Bong Lee Yeong Wook Song Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” Journal of Immunology Research |
| title | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
| title_full | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
| title_fullStr | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
| title_full_unstemmed | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
| title_short | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
| title_sort | erratum to low baseline interleukin 17a levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients |
| url | http://dx.doi.org/10.1155/2017/7869412 |
| work_keys_str_mv | AT sangjinlee erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT wonpark erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT sunghwanpark erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT seungcheolshim erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT hanjoobaek erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT daehyunyoo erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT hyunahkim erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT sookonlee erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT yunjonglee erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT youngeunpark erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT hoonsukcha erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT jinkyunpark erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT eunyounglee erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT eunbonglee erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT yeongwooksong erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients |